Integrated Diagnostics (IDHC) Competitors

Integrated Diagnostics (LON:IDHC) and Diaceutics (LON:DXRX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Is IDHC or DXRX more profitable?

Integrated Diagnostics has a net margin of 17.21% compared to Diaceutics' net margin of -10.90%. Integrated Diagnostics' return on equity of 30.45% beat Diaceutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integrated Diagnostics	17.21%	30.45%	9.69%
Diaceutics	-10.90%	-7.15%	-6.06%

Which has more risk & volatility, IDHC or DXRX?

Integrated Diagnostics has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Does the media favor IDHC or DXRX?

In the previous week, Integrated Diagnostics and Integrated Diagnostics both had 1 articles in the media. Integrated Diagnostics' average media sentiment score of 0.75 beat Diaceutics' score of -0.52 indicating that Integrated Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integrated Diagnostics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Diaceutics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Which has preferable valuation and earnings, IDHC or DXRX?

Integrated Diagnostics has higher revenue and earnings than Diaceutics. Diaceutics is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated Diagnostics	£23.29T	0.00	£4.01T	£0.03	11.97
Diaceutics	£26.08M	4.12	-£2.84M	-£3.37	-37.72

Do insiders and institutionals believe in IDHC or DXRX?

43.0% of Integrated Diagnostics shares are owned by institutional investors. Comparatively, 52.4% of Diaceutics shares are owned by institutional investors. 34.0% of Integrated Diagnostics shares are owned by company insiders. Comparatively, 34.3% of Diaceutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate IDHC or DXRX?

Diaceutics has a consensus target price of GBX 168.33, indicating a potential upside of 32.35%. Given Diaceutics' stronger consensus rating and higher possible upside, analysts clearly believe Diaceutics is more favorable than Integrated Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integrated Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Integrated Diagnostics beats Diaceutics on 9 of the 15 factors compared between the two stocks.